Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LataMed AILMEDD +9.76%26 Forward Dividend Yield % is 0.00% as of Jul. 17, 2026. GuruFocus rates LMEDD with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 992 Software companies, LataMed AI ranks worse than 100806.35% on this metric.
As of today (2026-07-17), the Forward Annual Dividend Yield of LataMed AI is 0.00%.
As of today (2026-07-17), the Trailing Annual Dividend Yield of LataMed AI is 0.00%.
LMEDD's Forward Dividend Yield % is not ranked *
in the Software industry.
Industry Median: 2.405 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
LataMed AI (OTCPK:LMEDD) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
LMEDD vs KLTR, BZAI, THRY: Forward Dividend Yield % Comparison
For the Software - Application subindustry, LataMed AI's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LataMed AI Forward Dividend Yield % vs Software Industry
For the Software industry and Technology sector, LataMed AI's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where LataMed AI's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
LataMed AI (LMEDD) has a Forward Dividend Yield % of 0.00% as of Jul. 17, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on LataMed AI and its competitors. According to the industry distribution chart, LataMed AI ranks #999999 out of 992 companies in the Software industry.
Is LataMed AI's Forward Dividend Yield % too high?
LataMed AI's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, LataMed AI ranks #999999 out of 992 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, LataMed AI has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's Forward Dividend Yield % compare to KLTR and BZAI?
According to the Software industry distribution chart, LataMed AI ranks #999999 out of 992 companies for Forward Dividend Yield %. This places LataMed AI in the lower half of its industry. The industry median Forward Dividend Yield % is 2.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Software company?
The median Forward Dividend Yield % among Software companies is 2.41, based on 992 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on LataMed AI and its competitors. For the Software industry, the median Forward Dividend Yield % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LataMed AI's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMEDD) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. LataMed AI's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For LataMed AI (LMEDD), the current Forward Dividend Yield % is 0.00% as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
26GF Score
Get the complete analysis for LMEDD
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMEDD has been successfully added to your 
